Research Article
Diagnostic and Prognostic Role of Serum Omentin and NGAL Levels in Egyptian Breast Cancer Patients
Table 1
Clinicopathological data of analyzed cases.
| | | Number of cases | % |
| Age | <40 | 12 | 10 | ≥40 | 108 | 90 |
| Tumor size | T0-T1 | 24 | 20 | T2 | 24 | 20 | T3 | 24 | 20 | T4 | 48 | 40 |
| Lymph node | N0 | 8 | 6.7 | N1 | 48 | 40 | N2 | 14 | 11.7 | N3 | 46 | 38.3 | Unknown (X) | 4 | 3.3 |
| Metastasis | Yes | 24 | 20 | No | 96 | 80 |
| Tumor grade | G1 | 2 | 1.7 | G2 | 86 | 71.7 | G3 | 12 | 10 | Unknown (X) | 20 | 16.6 |
| Estrogen receptor (ER) | Positive | 52 | 43.3 | Negative | 48 | 40 | Unknown (X) | 20 | 16.7 |
| Progesterone receptor (PR) | Positive | 40 | 33.3 | Negative | 60 | 50 | Unknown (X) | 20 | 16.7 |
| HER2 | Positive | 14 | 11.7 | Negative | 48 | 40 | Unknown (X) | 58 | 48.3 |
|
|